Elevation Oncology Inc. - Bathi mangsa ngarep ELEV

ELEV (elevationoncology.com) - tandha merek perusahaan

Elevation Oncology develops unique antibodies to combat genetic mutations. The projected profit volume shown on this GURU.Markets chart currently stands at . Geopolitical tensions and sanctions could hinder component procurement and testing. Meanwhile, patent protection for ADC therapy of solid tumors provides the company with a sustainable advantage in its narrow niche.

ELEV: Bathi mangsa ngarep elevationoncology.com 04.07.2022 - 17.11.2026

Elevation Oncology - rincian analitis lan metrik utama (ELEV)

Analisis fundamental perusahaan:Elevation Oncology Inc., ELEV
Barang utama Elevation Oncology Inc.

For Elevation Oncology (ELEV), the expected earnings per share reflect the commercial potential of developing targeted therapies for solid tumors. This metric aggregates analyst forecasts, smoothing out quarterly reporting gaps to identify the true profitability trend. By analyzing the company's estimated profit trajectory, an investor can observe the dynamics of the business's fundamental value. Steady growth confirms the effectiveness of the R&D strategy and management's competence. However, acquiring the asset at local peaks on the chart increases the risk of a long-term capital correction.

Pesaing Elevation Oncology

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Bathi sing dikarepake|Checkpoint Therapeutics, Inc (CKPT) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep ICAD|ikenaoncology.com (IKNA) - Prakiraan bathi perusahaan|Bathi sing dikarepake Notable Labs, Ltd. (NTBL)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake